Literature DB >> 8444122

Epidemiology and natural history of obstructive sleep apnea.

S Redline1, T Young.   

Abstract

The currently available data suggest that sleep apnea occurs commonly. Prevalence, however, varies markedly according to definitions utilized to characterize the disorder and the population studied; and has been reported to range from 1% (in an industrial working Israeli population) to 42% (in an elderly nursing home population). The degree to which sleep apnea contributes to the pathogenesis of other diseases is not entirely clear. Data from a number of sources suggest that sleep apnea may increase vascular morbidity and that excess mortality may occur in untreated patients. However, the degree to which mortality and morbidity may be influenced by more aggressive treatment of subjects with sleep apnea is not known. In particular, there is a need to better distinguish "clinically" significant sleep apnea from levels of apnea that may have few acute or chronic effects, and to define which segments of the population are at greatest risk for such adverse outcomes.

Entities:  

Mesh:

Year:  1993        PMID: 8444122

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  14 in total

Review 1.  Pediatric origins of adult lung diseases. 3: the genesis of adult sleep apnoea in childhood.

Authors:  F McNamara; C E Sullivan
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 2.  Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.

Authors:  Adam V Benjafield; Najib T Ayas; Peter R Eastwood; Raphael Heinzer; Mary S M Ip; Mary J Morrell; Carlos M Nunez; Sanjay R Patel; Thomas Penzel; Jean-Louis Pépin; Paul E Peppard; Sanjeev Sinha; Sergio Tufik; Kate Valentine; Atul Malhotra
Journal:  Lancet Respir Med       Date:  2019-07-09       Impact factor: 30.700

3.  Effect of asthma on the risk of obstructive sleep apnea syndrome in atopic women.

Authors:  Maninder Kalra; Jocelyn Biagini; David Bernstein; Sherry Stanforth; Jeffrey Burkle; Aliza Cohen; Grace LeMasters
Journal:  Ann Allergy Asthma Immunol       Date:  2006-08       Impact factor: 6.347

4.  When Does the Risk for Obstructive Sleep Apnea Start? The Importance of Perinatal Factors.

Authors:  Pablo E Brockmann
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

5.  Heritability of abnormalities in cardiopulmonary coupling in sleep apnea: use of an electrocardiogram-based technique.

Authors:  Lamia H Ibrahim; Frank J Jacono; Sanjay R Patel; Robert J Thomas; Emma K Larkin; Joseph E Mietus; Chung-Kang Peng; Ary L Goldberger; Susan Redline
Journal:  Sleep       Date:  2010-05       Impact factor: 5.849

6.  Green tea catechin polyphenols attenuate behavioral and oxidative responses to intermittent hypoxia.

Authors:  Isabel C Burckhardt; David Gozal; Ehab Dayyat; Yu Cheng; Richard C Li; Aviv D Goldbart; Barry W Row
Journal:  Am J Respir Crit Care Med       Date:  2008-02-14       Impact factor: 21.405

7.  Lack of association of the APOE epsilon 4 allele with the risk of obstructive sleep apnea: meta-analysis and meta-regression.

Authors:  Tushar P Thakre; Manju R Mamtani; Hemant Kulkarni
Journal:  Sleep       Date:  2009-11       Impact factor: 5.849

8.  A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apnea.

Authors:  Ian M Colrain; Jed Black; Lawrence C Siegel; Richard K Bogan; Philip M Becker; Mehran Farid-Moayer; Rochelle Goldberg; D Alan Lankford; Andrew N Goldberg; Atul Malhotra
Journal:  Sleep Med       Date:  2013-07-17       Impact factor: 3.492

9.  Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing.

Authors:  Shahrad Taheri; Diane Austin; Ling Lin; F Javier Nieto; Terry Young; Emmanuel Mignot
Journal:  Sleep       Date:  2007-08       Impact factor: 5.849

10.  Neurocognitive consequences of sleep deprivation.

Authors:  Namni Goel; Hengyi Rao; Jeffrey S Durmer; David F Dinges
Journal:  Semin Neurol       Date:  2009-09-09       Impact factor: 3.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.